This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (334)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

National Cancer Institute Workshop

JAMA. 1989;262(7):931-934.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE DEATH rate from cervical cancer has dropped significantly in the last 40 years, a decrease that has been attributed largely to the widespread use of the "Pap test." Recent criticism of cervical/ vaginal cytology, however, has focused the attention of the medical profession, governmental agencies, and legislative bodies on the need for strengthening quality assurance measures in cytopathology. One critical aspect of quality assurance in cervical/vaginal cytology is communication of the cytopathologic findings to the referring physician in unambiguous diagnostic terms that have clinical relevance. Terminology currently used is varied and in some instances ambiguous, resulting in confusion about the clinical implications of the report.

As a result of this ambiguous terminology, the Division of Cancer Prevention and Control, National Cancer Institute (NCI), convened a workshop of expert consultants, distinguished cytopathologists, and representatives from national medical and other organizations (See "List of Workshop Participants") to review existing terminology and . . . [Full Text PDF of this Article]

Footnotes
This report was developed and approved at a National Cancer Institute Workshop in Bethesda, Md, December 12 and 13, 1988.

Reprint requests to Cytopathology Section, Bldg 10, Room 2A33, National Cancer Institute, Bethesda, MD 20892 (Diane Solomon, MD).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?